You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Anti-CD20

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

WOE of Anti-CD20 Therapies

Not yet recruiting
  • Multiple Sclerosis
  • (no location specified)
Oct 31, 2023

Lymphoma Trial in Houston (PCV20)

Not yet recruiting
  • Lymphoma
  • PCV20
  • Houston, Texas
    M D Anderson Cancer Center
Sep 20, 2023

HBV Reactivation in Anti CD20 Treatment

Active, not recruiting
  • Hepatitis B
    • Afula, Tsafon, Israel
      HaEmek Medical Center
    Mar 14, 2023

    Chronic Lymphocytic Leukemia, B-Cell Chronic Lymphocytic Leukemia, Lymphoma, B-Cell Trial run by the National Cancer Institute

    Not yet recruiting
    • Chronic Lymphocytic Leukemia
    • +2 more
    • Anti-CD19 and anti-CD20 bicistronic CAR T- cells
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Apr 10, 2023

    Relapsing Multiple Sclerosis Trial in Fort Collins, Farmington (Ublituximab)

    Recruiting
    • Relapsing Multiple Sclerosis
    • Ublituximab
    • Fort Collins, Colorado
    • +1 more
    May 26, 2023

    Nephrotic Syndrome Trial in Genova (Rituximab Biosimilar ABP 798, Daratumumab)

    Not yet recruiting
    • Nephrotic Syndrome
    • Genova, Italy
      IRCCS G. Gaslini
    Jan 19, 2023

    Systemic Lupus Erythematosus, Pulmonary Arterial Hypertension Trial in Beijing (Rituximab)

    Not yet recruiting
    • Systemic Lupus Erythematosus
    • Pulmonary Arterial Hypertension
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    Apr 13, 2023

    COVID-19 Infection in Patients Receiving Anti-CD20 Therapy

    Active, not recruiting
    • COVID-19
    • +3 more
    • Convalescent Plasma
    • Rochester, Minnesota
      Mayo Clinic
    Jul 15, 2022

    Follicular Lymphoma, Mantle Cell Lymphoma Trial in Rouen (Determination of COVID-19 vacciantion efficacy)

    Completed
    • Follicular Lymphoma
    • Mantle Cell Lymphoma
    • Determination of COVID-19 vacciantion efficacy
    • Rouen, France
      Centre Henri Becquerel
    Dec 22, 2022

    Primary Membranous Nephropathy Trial in Beijing (B007)

    Not yet recruiting
    • Primary Membranous Nephropathy
    • Beijing, China
      Peking university first hospital
    Dec 20, 2022

    Primary Immune Thrombocytopenia (ITP) Trial in Tianjin (TPO-RAs, TPO-RAs combining anti-CD 20 mAb)

    Not yet recruiting
    • Primary Immune Thrombocytopenia (ITP)
    • TPO-RAs
    • TPO-RAs combining anti-CD 20 monoclonal antibody
    • Tianjin, China
      Institute of Hematology and Blood Diseases Hospital, Chinese Aca
    Feb 7, 2023

    Early Stage Follicular Lymphoma WHO Grade 1/2 or 3a Trial in Heidelberg (Standard, Experimental)

    Recruiting
    • Early Stage Follicular Lymphoma WHO Grade 1/2 or 3a
    • Standard
    • Experimental
    • Heidelberg, Germany
      University Hospital Heidelberg
    Jul 10, 2022

    IgM MGUS, Waldenstrom Macroglobulinemia, Neuropathy;Peripheral Trial in Boston (Acalabrutinib, Rituximab)

    Recruiting
    • IgM MGUS
    • +2 more
    • Boston, Massachusetts
    • +1 more
    Nov 14, 2022

    Leukemia, Stem Cell Transplantation Trial in Munich (FBTA05)

    Withdrawn
    • Leukemia
    • Stem Cell Transplantation
    • Munich, Bavaria, Germany
      3. Medizinische Klinik, Klinikum rechts der Isar der TU München
    Dec 5, 2022

    Cladribine Therapy After Anti CD20 Therapy

    Active, not recruiting
    • Multiple Sclerosis
    • Cladribine Oral Tablet
    • +2 more
    • Lugano, Ticino, Switzerland
      Neurocenter of Southern Switzerland, Ospedale Regionale di Lugan
    Mar 22, 2022

    Membranous Nephropathy Trial in Bergamo, Ranica (MOR202)

    Recruiting
    • Membranous Nephropathy
    • Bergamo, BG, Italy
    • +1 more
    Mar 4, 2022

    Lymphoma, B-Cell, Lymphoma, Non-hodgkins, Chronic Lymphocytic Leukemia Trial run by the NCI (Anti-cluster of differentiation 19

    Terminated
    Has Results
    • Lymphoma, B-Cell
    • +3 more
    • Anti-cluster of differentiation 19 (CD19)-Chimeric Antigen Receptors (CAR) and Anti-cluster of differentiation 20 (CD20)-CAR T cells
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 26, 2022

    Mantle Cell Lymphoma Trial in Duarte (drug, procedure, biological)

    Not yet recruiting
    • Mantle Cell Lymphoma
    • Duarte, California
      City of Hope Medical Center
    Sep 20, 2023

    B-cell Non-Hodgkins Lymphoma (B-NHL) Trial (Odronextamab, REGN5837)

    Not yet recruiting
    • B-cell Non-Hodgkins Lymphoma (B-NHL)
    • (no location specified)
    Jan 5, 2023

    Shingles, Zoster Trial in Geneva, (recombinant zoster vaccine)

    Not yet recruiting
    • Shingles
    • Zoster
    • recombinant zoster vaccine
    • Geneva,, Switzerland
      University Hospitals of Geneva
    Oct 24, 2022

    Blastoid Variant Mantle Cell Lymphoma, Mantle Cell Lymphoma, Pleomorphic Variant Mantle Cell Lymphoma Trial in Duarte

    Not yet recruiting
    • Blastoid Variant Mantle Cell Lymphoma
    • +2 more
    • Biopsy
    • +8 more
    • Duarte, California
      City of Hope Medical Center
    May 15, 2023

    Lymphoma, Non-Hodgkin, Lymphoma, B-Cell, Chronic Lymphocytic Leukemia Trial in Milwaukee (CAR-20/19-T cells (1.0 x10^5

    Completed
    Has Results
    • Lymphoma, Non-Hodgkin
    • +3 more
    • CAR-20/19-T cells (1.0 x10^5 CAR-20/19-T cells/kg)
    • +3 more
    • Milwaukee, Wisconsin
      Froedtert Hospital & Medical College of Wisconsin
    Jun 26, 2022

    Acute Lymphoblastic Leukemia, in Relapse, Acute Lymphoblastic Leukemia With Failed Remission, Acute Lymphoblastic Leukemia

    Recruiting
    • Acute Lymphoblastic Leukemia, in Relapse
    • +5 more
    • CAR-20/19-T cells (1 x 10^5 CAR-20/19-T cells/kg)
    • +4 more
    • Milwaukee, Wisconsin
      Medical College of Wisconsin
    Sep 22, 2022

    Relapsed/Refractory Follicular Lymphoma, Marginal Zone Lymphoma (MZL) Trial in Chiang Mai (Odronextamab, Lenalidomide,

    Recruiting
    • Relapsed/Refractory Follicular Lymphoma
    • Marginal Zone Lymphoma (MZL)
    • Chiang Mai, Thailand
      Chiang Mai University
    Nov 20, 2023

    Follicular Lymphoma (FL) Trial in Noblesville (Odronextamab, Rituximab, Cyclophosphamide)

    Recruiting
    • Follicular Lymphoma (FL)
    • Noblesville, Indiana
      Investigative Clinical Research of Indiana
    Oct 18, 2023